Amplia Therapeutics Announces 2024 AGM Details
Company Announcements

Amplia Therapeutics Announces 2024 AGM Details

Amplia Therapeutics Ltd. (AU:ATX) has released an update.

Amplia Therapeutics Limited has announced its upcoming Annual General Meeting (AGM), set to take place at Grant Thornton in Melbourne on August 23, 2024. Shareholders are called to review the company’s financial performance and consider resolutions including the adoption of the Remuneration Report, re-election of board members, and approval of new share issues. The AGM will address key management decisions and strategic directions for the fiscal year ended March 31, 2024.

For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics’ Drug Fast-Tracked by FDA
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics Director Increases Stake
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics Expands ASX Presence
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App